TMCI · Insider Trading
Treace Medical Concepts, Inc. Common Stock
Every open-market purchase and sale reported by TMCI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | F | −25,457 | — |
| 2026-08-24 | John T. Treace | Chief Executive Officer | Buy | +55,944 | +$246.65K |
| 2026-08-12 | Sean F. Scanlan | Chief Innovation Officer | F | −9,814 | — |
| 2026-08-12 | Mark Hair | Chief Financial Officer | F | −37,102 | — |
| 2026-08-12 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | F | −16,253 | — |
| 2026-06-12 | John T. Treace | Chief Executive Officer | Buy | +24,606 | +$99.20K |
| 2026-06-11 | John T. Treace | Chief Executive Officer | Buy | +52,317 | +$210.97K |
| 2026-06-01 | John T. Treace | Chief Executive Officer | Buy | +50,000 | +$177.91K |
| 2026-05-28 | John T. Treace | Chief Executive Officer | Buy | +115,520 | +$340.59K |
| 2026-05-19 | Deepti Jain | Director | A | +30,000 | — |
| 2026-05-19 | John K Bakewell | Director | A | +30,000 | — |
| 2026-05-19 | Jane E Kiernan | Director | A | +30,000 | — |
| 2026-05-19 | Betsy Hanna | Director | A | +30,000 | — |
| 2026-05-19 | Lawrence W Hamilton | Director | A | +30,000 | — |
| 2026-05-19 | Lance A Berry | Director | A | +30,000 | — |
| 2026-05-14 | John T. Treace | Chief Executive Officer | Buy | +153,763 | +$375.51K |
| 2026-04-20 | Mark Hair | Chief Financial Officer | F | −11,547 | — |
| 2026-04-03 | Mark Hair | Chief Financial Officer | A | +100,000 | — |
| 2026-03-11 | Sean F. Scanlan | Chief Innovation Officer | F | −1,797 | — |
| 2026-03-11 | John T. Treace | Chief Executive Officer | F | −7,083 | — |
| 2026-03-11 | Mark Hair | Chief Financial Officer | F | −4,659 | — |
| 2026-03-11 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | F | −1,850 | — |
| 2026-02-11 | Sean F. Scanlan | Chief Innovation Officer | M | +16,875 | +$17.72K |
| 2026-01-23 | Mark Hair | Chief Financial Officer | MIXED | +357,963 | — |
| 2026-01-23 | John T. Treace | Chief Executive Officer | MIXED | +235,746 | — |
| 2026-01-23 | Gaetano Guglielmino | Chief Commercial Officer | A | +150,000 | — |
| 2026-01-23 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | MIXED | +253,049 | — |
| 2026-01-23 | Sean F. Scanlan | Chief Innovation Officer | MIXED | +316,000 | +$38.52K |
| 2026-01-13 | Mark Hair | Chief Financial Officer | F | −8,719 | — |
| 2026-01-13 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | F | −4,544 | — |
| 2026-01-13 | John T. Treace | Chief Executive Officer | F | −13,219 | — |
| 2025-12-03 | Guy Guglielmino | Chief Commercial Officer | F | −22,099 | — |
| 2025-10-28 | Sean F. Scanlan | Chief Innovation Officer | F | −208 | — |
| 2025-10-28 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | F | −984 | — |
| 2025-10-02 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | F | −16,884 | — |
| 2025-08-12 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | F | −10,515 | — |
| 2025-08-12 | Aaron Berutti | SVP, Sales | F | −4,907 | — |
| 2025-08-12 | Sean F. Scanlan | Chief Innovation Officer | F | −9,814 | — |
| 2025-08-12 | Mark Hair | Chief Financial Officer | F | −22,212 | — |
| 2025-07-22 | Sean F. Scanlan | Chief Innovation Officer | M | +33,437 | +$24.00K |
| 2025-05-21 | Lance A Berry | Director | A | +23,917 | — |
| 2025-05-21 | Lawrence W Hamilton | Director | A | +23,917 | — |
| 2025-05-21 | Deepti Jain | Director | A | +23,917 | — |
| 2025-05-21 | Richard W Mott | Director | A | +23,917 | — |
| 2025-05-21 | Betsy Hanna | Director | A | +23,917 | — |
| 2025-05-21 | Jane E Kiernan | Director | A | +23,917 | — |
| 2025-05-21 | John K Bakewell | Director | A | +23,917 | — |
| 2025-05-12 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | MIXED | +5,881 | −$14.28K |
| 2025-03-19 | Sean F. Scanlan | Chief Innovation Officer | MIXED | — | −$345.96K |
| 2025-03-11 | Scot Michael Elder | Chief Legl & Comp Off, CorpSec | F | −1,851 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| John T. Treace | Chief Executive Officer | 9,243,446 | $40.86M |
| Richard W Mott | Director | 1,230,611 | $5.44M |
| Mark Hair | Chief Financial Officer | 916,100 | $4.05M |
| Scot Michael Elder | Chief Legl & Comp Off, CorpSec | 753,226 | $3.33M |
| Sean F. Scanlan | Chief Innovation Officer | 679,863 | $3.00M |
| Gaetano Guglielmino | Chief Commercial Officer | 490,901 | $2.17M |
| John K Bakewell | Director | 454,056 | $2.01M |
| Aaron Berutti | SVP, Sales | 205,092 | $906.51K |
| Deepti Jain | Director | 100,243 | $443.07K |
| Jane E Kiernan | Director | 93,949 | $415.25K |
| Betsy Hanna | Director | 75,243 | $332.57K |
| Lance A Berry | Director | 74,593 | $329.70K |
| Lawrence W Hamilton | Director | 74,056 | $327.33K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TMCI quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.